The present invention is directed to compounds that are allosteric inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF-α mediated conditions.
Triphenyl monomers suitable for microstructured optical films
申请人:3M Innovative Properties Company
公开号:US08871315B2
公开(公告)日:2014-10-28
Optical films are described having a polymerized microstructured surface that comprises the reaction product of a polymerizable resin composition comprising at least one polymerizable ethylenically unsaturated triphenyl monomer. Also described are certain triphenyl(meth)acrylate monomers and polymerizable resin compositions.
Novel mono-, di- or tri-acrylate esters of 1,1,1-trishydroxyphenylethane are produced by acrylating 1, 1,1-tris (4′-hydroxyphenyl) ethane. The esters may be polymerized or copolymerized in the presence of a free-radical polymerization initiator.
The present invention is directed to compounds that are allosteric inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF-α mediated conditions.
本发明涉及肿瘤坏死因子受体 I 的异构抑制剂化合物、包含此类化合物的组合物,以及使用此类化合物及其组合物治疗 TNF-α 介导的疾病的方法。
BARRIER LAMINATE, GAS BARRIER FILM, DEVICE, AND METHOD FOR PRODUCING BARRIER LAMINATE
申请人:ITO Shigehide
公开号:US20090297771A1
公开(公告)日:2009-12-03
In a barrier laminate comprising at least one organic layer and at least one inorganic layer, the organic layer is formed by curing a polymerizable composition comprising a tri- or more-functional (meth)acrylate having a cyclic carbon structure. The barrier laminate has a smooth surface and high barrier property.